Picard Medical (PMI) Invested Capital (2024 - 2026)

Picard Medical has reported Invested Capital for 3 years, with the latest figure at $709000.0 in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 101.45% year-over-year to $709000.0; the trailing twelve-month figure through Mar 2026 stood at $709000.0 (up 101.45% YoY), and the FY2025 full-year result was $3.9 million, up 108.87% from the prior year.
• Invested Capital for Q1 2026 stood at $709000.0, down from $3.9 million in the prior quarter.
• The five-year high for Invested Capital was $8.0 million in Q3 2025, with the low at -$54.4 million in Q2 2025.
• Historically, Invested Capital has averaged -$25.0 million across 3 years, with a median of -$32.5 million in 2024.
• The largest YoY upside for Invested Capital was 122.51% in 2025 against a maximum downside of 83.67% in 2025.
• Picard Medical's Invested Capital stood at -$43.9 million in 2024, then surged by 108.87% to $3.9 million in 2025, then sank by 81.8% to $709000.0 in 2026.
• The last three Invested Capital figures came in at $709000.0 (Q1 2026), $3.9 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.